 |
AIDSinfo E-News: Offering HIV/AIDS Research, Clinical Trials, Prevention, and Treatment Information. |
|
AIDSinfo At-a-Glance Issue No. 16
June 3, 2005 AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful. FDANews FDA Announces Discontinuation of FortovaseDue to decreased demand, the FDA announced on May 27,
2005, the discontinuation of Fortovase, the soft-gel formulation of
saquinavir. Roche Pharmaceuticals, the
manufacturer of Fortovase, released a “Dear Health Care Provider” letter
informing health care providers that the drug will be discontinued by
February 15, 2006. Patients currently taking saquinavir soft-gel capsules
should contact their doctors to discuss their alternatives. Invirase, the hard-gel capsule
and tablet formulations of saquinavir mesylate, will continue to be marketed
by Roche. Read the FDA’s
release and Roche Pharmaceutical’s complete “Dear Health Care Provider”
letter. For
more information on both formulations, check out the AIDSinfo drug
fact sheet on saquinavir.
FDA
Announces Approval of Generic Version of Foscavir
On May 31, 2005, the FDA approved a
generic version of Foscavir (foscarnet sodium injection), originally approved
in 1991. One generic formulation of foscarnet sodium injection is being manufactured by Pharmaforce,
Inc. This product is used for the
treatment of cytomegalovirus (CMV) retinitis in patients with acquired
immunodeficiency syndrome (AIDS). Read the FDA’s release.
Women’s Health Webcast—June 7, 2005
The Health
Resources and Services Administration’s (HRSA) Office of Women’s Health and
the Maternal and Child Health Bureau (MCHB) Division of Healthy Start and
Perinatal Services are hosting a webcast, “More than Just a Number: Realities
of Women and HIV/AIDS,” that will address women and HIV/AIDS in the United
States. This webcast is scheduled for June 7, 2005, from 1:00 – 2:30 p.m.,
ET. Among the topics covered in this webcast are: the nature, scope, and prevalence of
HIV/AIDS among women in the United States; challenges faced by women and
their families affected by HIV/AIDS; provider issues related to serving women
living with HIV/AIDS, with emphasis on community settings; and systems-based
models of HIV/AIDS care for women and their families. Click here for more information
or to register for this presentation. Go to the Fact Sheets and Booklets
page of AIDSinfo for more
information about HIV/AIDS health issues and women such as: HIV
and Pregnancy Drug
Regimens for HIV Positive Pregnant Women Delivery
Options for HIV Positive Pregnant Women National HIV Testing
Day—June 27, 2005 There’s still time
to plan for and be part of National HIV Testing Day. This is an annual event
sponsored by the National Association of People with AIDS (NAPWA). NAPWA’s
goal is to encourage people at risk for HIV to get tested and learn their
status. The theme this year is “Take the Test, Take Control.” To find out more about National HIV
Testing day, go to National HIV Testing
Day. For more information about HIV testing, read the AIDSinfo
fact sheet, Testing HIV
Positive - Do I Have AIDS? ClinicalTrials.gov Info Please send comments or
suggestions to ContactUs@aidsinfo.nih.gov
|
|
|
|
You are currently subscribed to %%list.name%% as:
%%emailaddr%% Subscribe to AIDSinfo list serv here. |
|
Contact AIDSinfo Click on the Live Help button on the AIDSinfo home page and communicate with the staff in “real time.” |